Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
Bigg Boss Malayalam 6 Elimination Update: Jaanmoni Gets Evicted From Mohanlal’s Show? Here’s What We Know -
Vidya Balan's 'Do Aur Do Pyaar' Urban Boho Style Avatar Is Relatable And Inspiring, Check Her Modern Avatar! -
WCL: How to buy Tickets for World Championship of Legends? -
625% Dividend, 1:10 Split, 3 Bonus; FMCG ITC Makes Big Acquisition Announcement; Stock Target Prices In April -
Exam Pressure Does Not Exist; Studying Punctually is Crucial; Says Aditi, the PSEB 2024 Topper -
Suzuki Swift Hatchback Scores 4 Star Safety Rating At JNCAP – ADAS, New Engine & More -
Dell Introduces AI-Powered Laptops and Mobile Workstations for Enterprises in India -
Journey From Delhi To Ooty: Top Transport Options And Attractions
Aurobindo Pharma gets FDA nod for Sertraline Hydrochloride
New Delhi, Nov 7 (UNI) Pharmaceutical major Aurobindo Pharma Ltd today said it has received final approval from the US Food and Drug Administration (USFDA) to make and market a 20 mg dose of Sertraline Hydrochloride.
Sertraline, a generic equivalent of Pfizer's Zoloft, is used in the treatment of depressive disorder in adults, a company statement said.
UNI
AK
SG
PM1923
Comments
Story first published: Friday, November 7, 2008, 19:34 [IST]
